Lithium carbonate and ethanol induced "highs" in normal subjects. 1977

L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi

The responses of twenty-three normal male subjects to a standardized dose of 95% ethanol (1.32 ml/kg of body weight) were compared after two weeks of placebo and two weeks of therapeutic serum lithium ion levels (mean 0.91 mEq/liter). The study was a placebo controlled, split-half crossover, double-blind design. Prealcohol and postalcohol responses were assessed by self-rating scales of affect and mood, independent rater observation, perceptual-motor, and cognitive performance tasks. Pretreatment by lithium carbonate neither blocked nor dampened an alcohol-induced subjective "high" in normal subjects. A complex reciprocal interaction may exist between the effects of lithium and alcohol upon other behavioral attributes. Alcohol was seen to reverse aspects of lithium-induced dysphoria and there is a suggestion that lithium may attenuate alcohol-induced cognitive inefficiency.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D009048 Motor Skills Performance of complex motor acts. Motor Skill,Skill, Motor,Skills, Motor
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D004336 Drug Antagonism Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy. Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms
D004644 Emotions Those affective states which can be experienced and have arousing and motivational properties. Feelings,Regret,Emotion,Feeling,Regrets
D005059 Euphoria An exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states. Euphorias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
March 1988, Drug intelligence & clinical pharmacy,
L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
December 1977, The Western journal of medicine,
L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
November 1971, JAMA,
L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
April 1972, JAMA,
L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
November 1977, The New England journal of medicine,
L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
March 1988, British journal of clinical pharmacology,
L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
September 1987, Pharmacopsychiatry,
L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
January 1984, European neurology,
L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
August 1991, The Journal of dermatology,
L L Judd, and R B Hubbard, and L Y Huey, and P A Attewell, and D S Janowsky, and K I Takahashi
June 1985, Archives of neurology,
Copied contents to your clipboard!